| 000 | 01354 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517154613.0 | ||
| 264 | 0 | _c20181022 | |
| 008 | 201810s 0 0 spa d | ||
| 022 | _a1988-9518 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrados, M | |
| 245 | 0 | 0 |
_a[Usefulness of piperacillin/tazobactam resistance as a predictor of OXA-48 carbapenemase in Enterobacteriaceae]. _h[electronic resource] |
| 260 |
_bRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia _cAug 2017 |
||
| 300 |
_a299-300 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xanalysis |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xdrug effects |
| 650 | 0 | 4 |
_aEnterobacteriaceae _xdrug effects |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPenicillanic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPiperacillin _xpharmacology |
| 650 | 0 | 4 | _aPiperacillin, Tazobactam Drug Combination |
| 650 | 0 | 4 |
_abeta-Lactamases _xanalysis |
| 700 | 1 | _aFernández, S | |
| 700 | 1 | _aLara, N | |
| 700 | 1 | _aAlós, J I | |
| 773 | 0 |
_tRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia _gvol. 30 _gno. 4 _gp. 299-300 |
|
| 999 |
_c27207006 _d27207006 |
||